Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

t is being prepared.

?These three Phase II clinical trials sponsored by NCI are components of a clinical trials program designed to identify signals of clinical activity of ispinesib across multiple tumor types,? stated Dr. Andrew A. Wolff, Cytokinetics Senior Vice President of Clinical Research and Development and Chief Medical Officer. ?Although these three trials did not meet the protocol-specified criteria for progression, we are encouraged by the anti-cancer activity of ispinesib observed to date in three other Phase II trials in breast, ovarian and non-small cell lung cancers. Based on these data, we plan to move forward in further clinical development of ispinesib with a focused approach to the potential treatment of breast cancer with ispinesib.?

Clinical Trials of Ispinesib

Ispinesib has been the subject of a broad Phase II clinical trials program under the sponsorship of GlaxoSmithKline (GSK) and is also being developed in collaboration with the NCI. GSK has sponsored three Phase II clinical trials, one evaluating ispinesib as second- or third-line treatment for patients with locally advanced or metastatic breast cancer, one evaluating ispinesib as second-line treatment for patients with non-small cell lung cancer, and one evaluating ispinesib as second-line treatment for patients with advanced ovarian cancer. Enrollment in all of these trials has been closed. To date, clinical activity with ispinesib has been observed in breast cancer, in non-small cell lung cancer, and ovarian cancer with the more robust clinical activity observed in a Phase II clinical trial evaluating ispinesib in the treatment of metastatic breast cancer patients that have failed treatment with taxanes and anthracyclines. In this clinical trial, The best overall responses observed with ispinesib were partial responses in 4 of 45 evaluable patients as measured by the RECIST criteria. Responses were confirmed by independent radiology review and were seen in
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:3/30/2015)... 2015 Research and Markets ... of the "Urological Catheters - Global ... offering. This report analyzes the ... Units and US$ Thousands by the following ... Peritoneal Catheters), and Urinary Catheters (Foley Catheters, ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... addition of the "Marine Biotechnology - Global ... Annual estimates and forecasts are provided ... seven-year historic analysis is provided for these markets. ... and secondary research. This report analyzes ...
(Date:3/30/2015)... 30, 2015  Edelberg & Associates (EA) and ... kind, real-time medical coding software platform designed to ... and medical coder at the point of care.  ... ScribeAmerica, EA has successfully built, deployed and tested ... between scribe and medical coder that can radically ...
Breaking Medicine Technology:Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3
(Date:3/30/2015)... 2015 Wireless Analytics, LLC , ... been announced as one of the Boston Business Journal’s ... private companies in Massachusetts. The list represents 70 ... growth from 2011 through 2014. 2015 marks the ... has recognized Wireless Analytics’s revenue growth. The Danvers-based ...
(Date:3/30/2015)... 31, 2015 Thomas Peither and ... respected inspection readiness professionals — will conduct a ... the inspection process. , Attendees will learn exactly ... and what they look for when conducting an ... and roundtable discussions. This will assure attendees are ...
(Date:3/30/2015)... 2015 NAPW honors ... of the Year. Ms. Irey is recognized with this ... most-recognized networking organization of professional women in the country, ... of Professional Women is a powerfully vibrant networking community ... , “I take care of four offices, 24 employees ...
(Date:3/30/2015)... Healthpointe is proud to provide urine and ... throughout Southern California. The drug screen determines if ... can identify evidence of recent use of alcohol, prescription ... and students regularly choose Healthpointe as their drug screen ... screen program at Healthpointe include:, ,     Testing ...
(Date:3/30/2015)... VA (PRWEB) March 30, 2015 The ... sites and flexible biological manufacturing plants. This is primarily ... the business. , This has forced facilities to produce ... , The existing facilities have been forced to expand ... a change of ownership. , Most of these facilities ...
Breaking Medicine News(10 mins):Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4Health News:National Association of Professional Women Announces Stacey Lynne Irey, Office Manager at Mid Jersey Endodontic Group, a 2015 Professional Woman of the Year 2Health News:Drug Screens Now at Healthpointe 2Health News:Drug Screens Now at Healthpointe 3Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3
... have still not been able to arrive at conclusive ... treating bad breadth //. The choice of using mouthwashes, ... is left to convenience of an individual. ... scraping and brushing do appear to have some benefit ...
... assumption that the elderly patients who are depressed and ... till such time they come out of their depression. ... from such intervention modules. Infact, Researchers have confirmed that ... patients with diabetes and the extent to which they ...
... computer-based "surgery simulators" will be helpful in shaping better ... that surgeons trained with the simulators were able to ... performing an interventional technique to repair blockages in the ... Thursday, April 20, 9:35 a.m., at the 126th annual ...
... insulin that could revolutionize diabetic treatment has been rejected by ... can be inhaled and provides an ideal alternative to the ... ,Patients with both Type 1 and Type 2 diabetes can ... with this form of insulin has been projected to be ...
... do not change people’s behavior and are a mere ... Additionally, they have also called for directing these funds ... spending the amount on hosting high-profile advertising pushes. ... discussion at the Britain's Royal College of Nursing that ...
... died after a serious burn injury that occurred instantly after ... with a flammable gel for a skin problem. Apparently, this ... fire escape. ,All other patients have expressed profound ... to correct procedures, and are treating this incident as an ...
Cached Medicine News:Health News:Treating Bad Breath Yet A Challenge 2Health News:Surgery Simulators Offer Better Surgeons And Safer Surgeries 2Health News:High Cost Forces NHS To Reject Inhaled Insulin 2Health News:Health Promotion Drives Waste Money, Claim Nurses 2
... and Proteomic users should inquire about ... Preparation capability for run-to-run replication. Compact ... accommodates 4x750 ml up to 4550xg ... throughput screening, research and patient specimen ...
Inquire...
... Hybridization Oven/Shaker rigidly controls the temperature ... of hybridization and washing steps. This ... of nucleic acids and proteins immobilized ... with radioactive and nonradioactive labeling systems ...
... GeneMachines HybStation is the first automated system ... automates all thermal and wash cycles for ... glass slides. A 12-position GeneMachines HybStation ... while the individual ports allow for independent ...
Medicine Products: